AIAI Holdings Corporation Class A Common Stock
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- AIAI Holdings Corporation, a diversified AI-enabled holding company, engages in acquiring and growing portfolio companies across multiple industries through the application of Transformational AI to enhance operational performance, financial results, and long-term value creation. Ai^2^ focuses on integrating AI-driven improvements within portfolio operations to drive revenue growth, margin expansion, and cash-flow optimization across its investments. Main products and services: AI-enabled portfolio optimization services; technology-enabled operational enhancements; data-driven intelligence platforms applied to portfolio companies; integration of Transformational AI across supply chains, finance, and customer-facing processes; consulting and implementation services for AI deployment within portfolio businesses; ongoing portfolio management and strategic guidance to drive value creation; governance, risk management, and compliance oversight facilitated by AI-driven analytics. Founding year and headquarters: Founded in 2026; headquartered in Dallas, Texas, United States. Geographic operations and segments: Operates primarily in the United States with a strategy to pursue acquiring and growing businesses across sectors including infrastructure, natural resources, financial services, and technology; manages a diversified portfolio through strategic acquisitions and operating improvements powered by AI; maintains an international investor relations footprint accompanying its NASDAQ listing in 2026. Subsidiaries and corporate structure: Structured as a holding company with a portfolio of subsidiaries across industries, each benefiting from Ai^2^’s Transformational AI platform; operates under a centralized corporate umbrella to deploy AI-enabled playbooks, data platforms, and best-practice operating models across portfolio entities. Recent major changes: In 2026, Ai^2^ completes its public listing on the NASDAQ Global Market under the symbol AIAI, signaling a broader capital markets strategy and enhanced visibility to potential acquisitions; announces direct listing with a plan to pursue an active pipeline of strategic acquisitions and partnerships; files initial registration and pursues growth through partnerships and new AI-driven offerings to accelerate value creation across its portfolio. The company also confirms deployment of its Transformational AI platform across portfolio companies to boost efficiency, improve financial performance, and support scalable expansion. Industry and market position: Falls within the AI-enabled diversified holding company space, targeting cross-industry value creation through AI-enhanced operations; positions itself as a platform company integrating AI into its portfolio businesses to drive measurable performance improvements and long-term shareholder value. Target markets and customers: Enterprise and institutional investors seeking exposure to AI-driven, diversified corporate growth; portfolio companies seeking AI-enabled transformations to improve operations and financial results; strategic partners seeking collaboration on AI deployment and value creation across multiple industries.
Company News
AIAI Holdings to Present at the 20th Annual LD Micro Main Event
Rochon Family Executes Additional Strategic Purchase of $26.8 Million of AIAI Holdings Shares
NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright's AI-Based Drug Discovery and Development Conference
AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
AIAI Holdings Announces Letter of Intent with Messier 42 LLC to Acquire Controlling Interest in Defense & National Security Company
NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier
AIAI Holdings Commences Discussions with Messier 42 LLC Regarding Acquisition Opportunities
NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High
AIAI Holdings' CEO Todd Furniss Issues Shareholder Letter
AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence
AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare
AIAI Deploys Bid Accelerator, Showcasing Its Transformational AI Integration Strategy
AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner
AIAI Holdings' Constellation Network Launches Gate AI: Real-Time Security for AI Applications
AIAI Holdings' MediGuide Launches Digital Platform
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
AIAI Holdings Unveils AI Integration Playbook for Portfolio Companies